Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
50,360,102
-
Share change
-
+1,349,734
-
Total reported value
-
$10,157,640,692
-
Put/Call ratio
-
116%
-
Price per share
-
$201.82
-
Number of holders
-
601
-
Value change
-
+$259,182,756
-
Number of buys
-
300
-
Number of sells
-
266
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2023
As of 31 Mar 2023 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) had 601 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 50,360,102 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Clearbridge Investments, LLC, Allspring Global Investments Holdings, LLC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, and Jackson Square Partners, LLC.
This table shows 608 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.